Kiniksa Pharmaceuticals
Price & Volume
Stats
See more52W Range | $37.02-$98.48 |
Market Cap | $7.3B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $945.9M |
Revenue Growth (YoY) | 58.1% |
Gross Profit (12 Mos) | $513.3M |
Diluted EPS | $1.32 |
News
See moreYahoo Finance • 22 days ago
Biotech Stocks To Watch: Regeneron Partner Has Breakout In Sight
Yahoo Finance • 3 months ago
Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference
Yahoo Finance • 3 months ago
Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution
Yahoo Finance • 4 months ago
Kymera Appoints Felix Baker As Board Chairman, Succeeds Bruce Booth
About
CEO | Mr. Sanjiv K. Patel |
CFO | Mr. Mark A. Ragosa C.F.A. |
Address | 105 Piccadilly, London, United Kingdom, W1J 7NJ |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 366 |